TFA Therapeutics (RAJAF) Net Income (2020 - 2023)

TFA Therapeutics has reported Net Income for 4 years, with the latest figure at $61900.0 in Q4 2023.

• On a quarterly basis, Net Income fell 92.2% year-over-year to $61900.0 in Q4 2023; TTM through Dec 2023 was $470129.0, a N/A change from a year earlier, with the FY2025 full-year figure at $154822.0, down 31.57% from the prior year.
• Net Income was $61900.0 for Q4 2023 at TFA Therapeutics, down from $793331.0 in the prior quarter.
• The five-year high for Net Income was $793331.0 in Q4 2022, with the low at -$371626.0 in Q4 2021.
• Average Net Income over 4 years is $117532.2, with a median of $24212.0 recorded in 2020.
• The sharpest annual moves came in 2021 and 2022: Net Income plunged 2657.69% in 2021, then soared 313.48% in 2022.
• Over 4 years, Net Income stood at -$13476.0 in 2020, then slumped by 2657.69% to -$371626.0 in 2021, then jumped by 313.48% to $793331.0 in 2022, then slumped by 92.2% to $61900.0 in 2023.
• The last three Net Income figures came in at $61900.0 (Q4 2023), $793331.0 (Q4 2022), and -$371626.0 (Q4 2021), per Business Quant data.